These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24994843)

  • 1. Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia.
    Irwin DJ; McMillan CT; Suh E; Powers J; Rascovsky K; Wood EM; Toledo JB; Arnold SE; Lee VM; Van Deerlin VM; Trojanowski JQ; Grossman M
    Neurology; 2014 Aug; 83(6):502-9. PubMed ID: 24994843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic variation is associated with longitudinal decline and network features in behavioral variant frontotemporal degeneration.
    Massimo L; Rennert L; Xie SX; Olm C; Bove J; Van Deerlin V; Irwin DJ; Grossman M; McMillan CT
    Neurobiol Aging; 2021 Dec; 108():16-23. PubMed ID: 34474300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.
    McMillan CT; Toledo JB; Avants BB; Cook PA; Wood EM; Suh E; Irwin DJ; Powers J; Olm C; Elman L; McCluskey L; Schellenberg GD; Lee VM; Trojanowski JQ; Van Deerlin VM; Grossman M
    Neurobiol Aging; 2014 Jun; 35(6):1473-82. PubMed ID: 24373676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.
    Irwin DJ; McMillan CT; Xie SX; Rascovsky K; Van Deerlin VM; Coslett HB; Hamilton R; Aguirre GK; Lee EB; Lee VMY; Trojanowski JQ; Grossman M
    Brain; 2018 Jan; 141(1):288-301. PubMed ID: 29228211
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
    Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
    Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.
    Feis RA; Bouts MJRJ; Panman JL; Jiskoot LC; Dopper EGP; Schouten TM; de Vos F; van der Grond J; van Swieten JC; Rombouts SARB
    Neuroimage Clin; 2018; 20():188-196. PubMed ID: 30094168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
    Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
    Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
    Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
    Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.
    Borrego-Écija S; Morgado J; Palencia-Madrid L; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Balasa M; Antonell A; Molinuevo JL; Lladó A; Martínez de Pancorbo M; Gelpi E; Sánchez-Valle R
    Dement Geriatr Cogn Disord; 2017; 44(3-4):213-221. PubMed ID: 28934750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease.
    Lu PH; Lee GJ; Shapira J; Jimenez E; Mather MJ; Thompson PM; Bartzokis G; Mendez MF
    J Alzheimers Dis; 2014; 39(2):261-9. PubMed ID: 24150110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Illán-Gala I; Montal V; Borrego-Écija S; Vilaplana E; Pegueroles J; Alcolea D; Sánchez-Saudinós B; Clarimón J; Turón-Sans J; Bargalló N; González-Ortiz S; Rosen HJ; Gorno-Tempini ML; Miller BL; Lladó A; Rojas-García R; Blesa R; Sánchez-Valle R; Lleó A; Fortea J;
    Brain; 2019 Apr; 142(4):1121-1133. PubMed ID: 30906945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia.
    Yokoyama JS; Bonham LW; Sturm VE; Adhimoolam B; Karydas A; Coppola G; Miller BL; Rankin KP
    Neuroimage Clin; 2015; 9():283-90. PubMed ID: 26509115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.
    Seripa D; Bizzarro A; Pilotto A; Palmieri O; Panza F; D'Onofrio G; Gravina C; Archetti S; Daniele A; Borroni B; Padovani A; Masullo C
    J Alzheimers Dis; 2012; 31(4):731-40. PubMed ID: 22710912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort.
    Balasa M; Gelpi E; Martín I; Antonell A; Rey MJ; Grau-Rivera O; Molinuevo JL; Sánchez-Valle R; Lladó A;
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):882-92. PubMed ID: 25381753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
    Chen Q; Boeve BF; Schwarz CG; Reid R; Tosakulwong N; Lesnick TG; Bove J; Brannelly P; Brushaber D; Coppola G; Dheel C; Dickerson BC; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova RH; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford NR; Grossman M; Haley D; Heuer HW; Hsiung GR; Huey E; Irwin DJ; Jack CR; Jones DT; Jones L; Karydas AM; Knopman DS; Kornak J; Kramer J; Kremers W; Kukull WA; Lapid M; Lucente D; Lungu C; Mackenzie IRA; Manoochehri M; McGinnis S; Miller BL; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Sengdy P; Shaw L; Syrjanen J; Tatton N; Taylor J; Toga AW; Trojanowski J; Weintraub S; Wong B; Boxer AL; Rosen H; Wszolek Z; Kantarci K;
    Neurobiol Aging; 2019 Nov; 83():54-62. PubMed ID: 31585367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin-associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease.
    Siokas V; Aloizou AM; Liampas I; Bakirtzis C; Tsouris Z; Sgantzos M; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
    Acta Neurol Scand; 2022 Feb; 145(2):223-228. PubMed ID: 34694630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.